Developmental Funds

发展基金 摘要 在目前的赠款期间，CCSG发展基金已与慈善事业结合使用 通过支持试点项目，为促进新墨西哥州大学癌症中心的战略优先事项提供资金。联合国排雷行动委员会 试点赠款计划旨在加强多学科和跨学科癌症的协作 研究；促进癌症中心共享资源的使用，为校外赠款生成初步数据 应用；支持早期研究人员发起的临床试验；为毕业生提供匹配支持 学生和博士后研究员。新墨西哥州大学以及我们联盟的所有联东综合团成员 合作伙伴(Lovelace呼吸研究所、桑迪亚国家实验室和洛斯阿拉莫斯国家实验室 实验室)有资格申请。所有资金决定都是由CCSG高级领导层在经过正式、 由基础研究副主任Tomkinson博士组织的严格同行审查程序，并提供支持 来自癌症中心研究管理局。成果(出版物、授权、专利、临床试验) 在试点赠款终止后的5年内，通过要求提交年度进展报告来跟踪试点赠款。 自2010年以来，发放了40笔试点赠款，涉及50多名联东特派团成员。这项投资 来自CCSG发展基金的500,441美元和来自癌症中心慈善基金的200,388美元导致 在同行评议的期刊上发表了27篇文章，并向一名博士后授予了一项NCI K22奖学金， 6个NIH R01补助金(包括2个多PI R01)、3个NIH R21补助金和3个来自其他国家的补助金 资助机构(包括国防部资助的早期研究人员发起的临床试验)，a 直接费用返还88.488.72亿美元(总费用13013384美元)。此外，来自区域和国家的资金 国家基金会，包括牛仔癌症研究基金会、加布里埃尔天使基金会和 奥克斯纳德基金会，以及最近的Phi Beta Psi慈善信托基金，以及吉尔森-隆格堡和安德森基金会 基金会主要用于支持协作性翻译和临床重点研究 项目。美国癌症协会机构研究助学金支持新教师指导的试点项目 建立以癌症为重点的研究职业，包括行为研究职业。在下一个授权期内， 我们建议使用CCSG发展基金：1)资助试点赠款，以促进合作 以实验室为基础的癌症研究、临床癌症研究、 基于人群的癌症研究，癌症健康差异和涉及学术- 社区伙伴关系和社区参与战略；2)支持开发新的 行为测量和人口科学共享资源，将催化和支持癌症- 以患者为中心的相关研究和人口科学研究；3)支持一名特殊人口工作人员调查员， Cosette Wheeler博士将专注于全州、全国和全球癌症的战略发展 预防研究计划。

DEVELOPMENTAL FUNDS ABSTRACT In the current grant period, CCSG Developmental Funds have been used in combination with philanthropic funds to promote the strategic priorities of the UNM Cancer Center by supporting pilot projects. The UNMCC pilot grant program was designed to; enhance collaborative multidisciplinary and transdisciplinary cancer research; promote the use of Cancer Center Shared Resources to generate preliminary data for extramural grant applications; support early phase, investigator-initiated clinical trials; provide matching support for graduate students and postdoctoral fellows. All UNMCC members at New Mexico Universities, as well as at our consortium partners (Lovelace Respiratory Research Institute, Sandia National Laboratories and Los Alamos National Laboratory) were eligible to apply. All funding decisions were made by the CCSG senior leadership after a formal, rigorous peer review process organized by Dr. Tomkinson, Associate Director for Basic Research, with support from the Cancer Center Research Administration. Outcomes (publications, grants, patents, clinical trials) from the pilot grants are tracked by requesting annual progress reports for 5 years after the award has terminated. Since 2010, 40 pilot grants involving more than 50 UNMCC members have been awarded. This investment of $500,441 from CCSG Developmental funds and $200,388 from Cancer Center philanthropic funds resulted in twenty seven publications in peer-reviewed journals and the award of one NCI K22 grant to a postdoctoral fellow, six NIH R01 grants (including two multi-PI R01s), three NIH R21 grants and three grants from other national funding agencies (including a Department of Defense-funded early phase investigator-initiated clinical trial), a return of $8,848,872 million in direct costs ($13,013,384 total costs). In addition, funds from regional and national foundations national foundations including Cowboy's for Cancer Research, Gabrielle's Angel Foundation, and Oxnard Foundation and, more recently, Phi Beta Psi Charity Trust, and the Gillson-Longenbaugh and Anderson Foundations have been used primarily to support collaborative translational and clinically focused research projects. An American Cancer Society Institutional Research Grant supports mentored pilot projects by new faculty establishing cancer-focused research careers, including careers in behavioral research. In the next grant period, we are proposing to use CCSG Developmental funds to; 1) fund pilot grants that promote collaborative multidisciplinary and interdisciplinary research in laboratory-based cancer research, clinical cancer research, population-based cancer research, cancer health disparities and catchment area studies involving academic- community partnerships, and community engagement strategies; 2) support the development of a new Behavioral Measurement and Population Science Shared Resource that will catalyze and support cancer- relevant patient-centered and population science research; 3) support a Special Populations Staff Investigator, Dr. Cosette Wheeler, who will focus on strategic development of statewide, national, and global cancer prevention research initiatives.